This system mediates neuroprotection, synaptogenesis, cerebral blood flow, long-term potentiation and memory consolidation and retrieval
Hims told investors it plans to largely end compounded semaglutide, but that it would continue compounding personalized doses for some patients
Healthcare providers are advised to closely monitor TFTs and adjust levothyroxine dosing as necessary, especially during the initial months of semaglutide therapy or with significant changes in weight
If you are on thyroid hormone medication, prior to starting Trulicity, please review the timing of taking your thyroid hormone medication with the doctor who prescribes it as it may need to be adjusted.The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on Trulicity
The relationship between GLP-1 therapies and atrial fibrillation is an emerging topic in diabetes care, raising an important question: could medications designed to protect the heart also influence its rhythm
Patient Selection and Practical Considerations Selecting the right patient is critical for the safe and effective use of GLP-1 adjunct therapy in type 1 diabetes
